No abstract

No abstract

UV irradiation of Aspergillus ochraceus NRRL 3174 conidia led to stable mutations in ochratoxin and penicillic-acid pathways. These mutants, especially M18, produced an unexpectedly large number of new metabolites. Two new compounds were purified by TLC and HPLC and their chemical structures were determined. They are 2,10-dimethyl 4-hydroxy-6-oxo-4-undecen-7-yne (1) and 4-(3-methyl-2- butenyl) oxy 1-phenyl acetic acid (2). Compound 1 is very active against Gram-positive bacteria, such as Staphylococcus aureus and Bacillus subtilis, but inactive against Gram-negative bacteria, fungi, and yeasts. However, compound 2 has no antibiotic activity. The production of 1 was generally associated with growth, whereas that of compound 2 was dissociated from growth. The biosynthesis of these 2 metabolites was influenced by the sources of carbon and nitrogen.

Biofiltration technology has been recognized as a promising biotechnology for treating the volatile organic compounds (VOCs) present in polluted air. This study aims to investigate the performance of a biofiltration system of Streptomyces griseus sp. DSM-40759 immobilized on activated carbon (PICA S23) towards the adsorption and degradation of toluene vapour as well as to regenerate the activated carbon in situ. The batch studies were performed using nutrient agar medium and basal salt medium (BSM) for microbial growth. Initially the pre-cultures were incubated at a temperature of 28°C on a rotary shaker at 150 rpm. After two days, the strain S. griseus DSM-40759 was immobilized on a known weight of activated carbon (12 g). The results of biofilter performance showed three different stages with a quick adsorption phase with approximately 95% of toluene removal after 70 min, a slow biotransformation phase by immobilized cells. In the later, the removal efficiency decreased significantly with the extension of time and reached 60% during this stage. Moreover, a final quick removal phase by the immobilized cells had an average removal efficiency of toluene around 95% after 500 min. The toluene degradation was found to be more than 84% after the second cycle and the biofilter was still capable of removing additional toluene. Thus, the results demonstrated the feasibility and reusability of a new biofilter system for toluene removal as well as extending the activated carbon's capacity and this could be a potential solution to reuse the activated carbon in industrial application.

The aim of the present work is the development and evaluation of solid lipid nanoparticles (SLNs) as carrier system for topical delivery of benzocaine (BZC) improving its local anesthesia aiming to produce a fast acting and long lasting topical formulation. BZC loaded SLNs were prepared using a full factorial design to study the influence of the type of polyoxyethylene sorbitan ester surfactants as well as their concentration as independent variables on the particle size, entrapment efficacy and zeta potential selected as dependent variables. Design of experiment (DOE) and the analysis of variance (ANOVA) were conducted to assess the optimization of the developed formulations. The results indicated that the fatty acid chain length of tested surfactants and their concentration had a significant effect on the studied responses. The optimized formulations were spherical in shape of mean particle diameters<350 nm with negatively charged surface <-20mV. Particles were characterized using differential scanning calorimetry and X-ray powder diffraction confirming the amorphous nature and the uniformity of drug inclusion in the lipid matrix. Optimized BZC-SLNs were incorporated into hydrogels characterized by a pseudoplastic non-Newtonian behavior. In vitro release study revealed an apparently biphasic release process with sustained release profile following Higuchi kinetics. BZC loaded SLNs hydrogels showed more potent anesthetic effect compared to BZC hydrogel evaluated using tail-flick analgesimeter, confirming significant improvement in both the intensity and duration of anesthetic effect. The above results proved that SLNs represent good candidates to encapsulate BZC improving its therapeutic efficacy for the topical treatment of pain.